Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis

Kidney International

Volumn 80, Issue 10, 2011, Pages 1035-1044

  Sörensen, Inga ^a   Susnik, Nathan ^a   Inhester, Therese ^a   Degen, Jay L ^b   Melk, Anette ^a   Haller, Herrmann ^a   Schmitt, Roland ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FIBRINOGEN DEFECT; FIBROBLAST; KIDNEY FIBROSIS; LEYDIG CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION;

EID: 80255133190     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.214     Document Type: Article

References (49)

1. Clark RA. Fibrin is a many splendored thing. J Invest Dermatol 2003; 121: xxi-xxii. (Pubitemid 37430957)
2. Laurens N, Koolwijk P, de Maat MP. Fibrin structure and wound healing. J Thromb Haemost 2006; 4: 932-939.
3. Flick MJ, LaJeunesse CM, Talmage KE et al. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. J Clin Invest 2007; 117: 3224-3235. (Pubitemid 350096980)
4. Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med 2007; 204: 1999-2008. (Pubitemid 47236333)
5. Drew AF, Liu H, Davidson JM et al. Wound-healing defects in mice lacking fibrinogen. Blood 2001; 97: 3691-3698.
6. de Giorgio-Miller A, Bottoms S, Laurent G et al. Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator. Am J Pathol 2005; 167: 721-732. (Pubitemid 41216357)
7. Masamune A, Kikuta K, Watanabe T et al. Fibrinogen induces cytokine and collagen production in pancreatic stellate cells. Gut 2009; 58: 550-559.
8. Vidal B, Serrano AL, Tjwa M et al. Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev 2008; 22: 1747-1752. (Pubitemid 351915499)
9. Hewitson TD. Renal tubulointerstitial fibrosis: common but never simple. Am J Physiol Renal Physiol 2009; 296: F1239-F1244.
10. Kincaid-Smith P. Coagulation and renal disease. Kidney Int 1972; 2: 183-190.
11. Bruno NE, Yano Y, Takei Y et al. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency. Thromb Haemost 2008; 100: 90-100. (Pubitemid 351948750)
12. Shin JI, Park JM, Shin YH et al. Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children. J Clin Pathol 2005; 58: 1147-1151. (Pubitemid 41566457)
13. Drew AF, Tucker HL, Liu H et al. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol 2001; 281: F1157-F1163.
14. Yamaguchi I, Lopez-Guisa JM, Cai X et al. Endogenous urokinase lacks antifibrotic activity during progressive renal injury. Am J Physiol Renal Physiol 2007; 293: F12-F19. (Pubitemid 47344995)
15. Eddy AA. Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost 2009; 101: 656-664.
16. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts Derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350. (Pubitemid 34847966)
17. Le Hir M, Hegyi I, Cueni-Loffing D et al. Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem Cell Biol 2005; 123: 335-346. (Pubitemid 40922217)
18. Tsujie M, Isaka Y, Ando Y et al. Gene transfer targeting interstitial fibroblasts by the artificial viral envelope-type hemagglutinating virus of Japan liposome method. Kidney Int 2000; 57: 1973-1980. (Pubitemid 30252289)
19. Grgic I, Kiss E, Kaistha BP et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci USA 2009; 106: 14518-14523.
20. Picard N, Baum O, VogetseDer A et al. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 2008; 130: 141-155.
21. Gardiner EE, D'Souza SE. A mitogenic action for fibrinogen mediated through intercellular adhesion molecule-1. J Biol Chem 1997; 272: 15474-15480. (Pubitemid 27255574)
22. Hao S, Shen H, Hou Y et al. tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling. Am J Pathol 2010; 177: 1164-1175.
23. Li Y, Tan X, Dai C et al. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 2009; 20: 1907-1918.
24. Pulskens WP, Rampanelli E, Teske GJ et al. TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 2010; 21: 1299-1308.
25. Campbell MT, Hile KL, Zhang H et al. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res 2009.
26. AnDers HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010; 21: 1270-1274.
27. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-2894. (Pubitemid 32768923)
28. Pierer M, Rethage J, Seibl R et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 2004; 172: 1256-1265. (Pubitemid 38113789)
29. Leemans JC, Butter LM, Pulskens WP et al. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 2009; 4: e5704.
30. Matsushita Y, Hasegawa M, Matsushita T et al. Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice. J Immunol 2007; 179: 698-707. (Pubitemid 46986589)
31. Ruppert C, Markart P, Wygrecka M et al. Role of coagulation and fibrinolysis in lung and renal fibrosis. Hamostaseologie 2008; 28: 30-32, 34-36.
32. Boyd JH, Chau EH, Tokunanga C et al. Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism. Crit Care 2008; 12: R2.
33. Patibandla PK, Tyagi N, Dean WL et al. Fibrinogen induces alterations of endothelial cell tight junction proteins. J Cell Physiol 2009; 221: 195-203.
34. Ramila D, Ardura JA, Esteban V et al. Parathyroid hormone-related protein promotes inflammation in the kidney with an obstructed ureter. Kidney Int 2008; 73: 835-847. (Pubitemid 351398283)
35. Chow FY, Nikolic-Paterson DJ, Ozols E et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 2005; 16: 1711-1722. (Pubitemid 41716477)
36. Janssen U, Ostendorf T, Gaertner S et al. Improved survival and amelioration of nephrotoxic nephritis in intercellular adhesion molecule-1 knockout mice. J Am Soc Nephrol 1998; 9: 1805-1814. (Pubitemid 28443477)
37. Motojima M, Matsusaka T, Kon V et al. Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro. Nephron Exp Nephrol 2010; 114: e39-e47.
38. Gluba A, Banach M, Hannam S et al. The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 2010; 6: 224-235.
39. Chowdhury P, Sacks SH, Sheerin NS. Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephron Exp Nephrol 2010; 115: e122-e130.
40. Tang L, Ugarova TP, Plow EF et al. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996; 97: 1329-1334. (Pubitemid 26085490)
41. Hattori N, Degen JL, Sisson TH et al. Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice. J Clin Invest 2000; 106: 1341-1350.
42. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-609. (Pubitemid 36456957)
43. Bash LD, Erlinger TP, Coresh J et al. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 2009; 53: 596-605.
44. Fried L, Solomon C, Shlipak M et al. Inflammatory and prothrombotic markers and the progression of renal disease in elDerly individuals. J Am Soc Nephrol 2004; 15: 3184-3191. (Pubitemid 39578851)
45. Suh TT, Holmback K, Jensen NJ et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev 1995; 9: 2020-2033.
46. Adams J, Kiss E, Arroyo AB et al. 13-cis retinoic acid inhibits development and progression of chronic allograft nephropathy. Am J Pathol 2005; 167: 285-298. (Pubitemid 40884789)
47. Schmitt R, Marlier A, Cantley LG. Zag expression during aging suppresses proliferation after kidney injury. J Am Soc Nephrol 2008; 19: 2375-2383.
48. Grimwood L, Masterson R. Propagation and culture of renal fibroblasts. Methods Mol Biol 2009; 466: 25-37.
49. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408. (Pubitemid 34164012)